These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16803540)
61. [Familial and genetic study in a large Chinese kindred with hereditary nonpolyposis colorectal cancer]. Li TG; Liu XP; Zheng D; Sun JC; Li J; Tan ZP; Qin ZQ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):227-9. PubMed ID: 17407090 [TBL] [Abstract][Full Text] [Related]
63. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC). Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318 [TBL] [Abstract][Full Text] [Related]
64. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome. Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446 [TBL] [Abstract][Full Text] [Related]
65. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Halvarsson B; Lindblom A; Rambech E; Lagerstedt K; Nilbert M Virchows Arch; 2004 Feb; 444(2):135-41. PubMed ID: 14652751 [TBL] [Abstract][Full Text] [Related]
66. HNPCC: six new pathogenic mutations. Kunstmann E; Vieland J; Brasch FE; Hahn SA; Epplen JT; Schulmann K; Schmiegel W BMC Med Genet; 2004 Jun; 5():16. PubMed ID: 15217520 [TBL] [Abstract][Full Text] [Related]
68. Impact of 226C>T MSH2 gene mutation on cancer phenotypes in two HNPCC-associated highly-consanguineous families from Kuwait: emphasis on premarital genetic testing. Marafie MJ; Al-Awadi S; Al-Mosawi F; Elshafey A; Al-Ali W; Al-Mulla F Fam Cancer; 2009; 8(4):289-98. PubMed ID: 19669601 [TBL] [Abstract][Full Text] [Related]
69. Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer. Hirai Y; Banno K; Suzuki M; Ichikawa Y; Udagawa Y; Sugano K; Miki Y Cancer Sci; 2008 Sep; 99(9):1715-9. PubMed ID: 18624996 [TBL] [Abstract][Full Text] [Related]
70. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature. Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254 [TBL] [Abstract][Full Text] [Related]
71. The predicted truncation from a cancer-associated variant of the MSH2 initiation codon alters activity of the MSH2-MSH6 mismatch repair complex. Cyr JL; Brown GD; Stroop J; Heinen CD Mol Carcinog; 2012 Aug; 51(8):647-58. PubMed ID: 21837758 [TBL] [Abstract][Full Text] [Related]
72. An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents. Kucherlapati MH; Lee K; Nguyen AA; Clark AB; Hou H; Rosulek A; Li H; Yang K; Fan K; Lipkin M; Bronson RT; Jelicks L; Kunkel TA; Kucherlapati R; Edelmann W Gastroenterology; 2010 Mar; 138(3):993-1002.e1. PubMed ID: 19931261 [TBL] [Abstract][Full Text] [Related]
73. Confirmation of damaging effect of MSH2 c.2634+1G>C mutation on splicing, its classification and implications for counseling. Rakobradović J; Krivokuća A; Jovandić S; Kesić V; Branković-Magić M Cancer Genet; 2019 Nov; 239():1-7. PubMed ID: 31437759 [TBL] [Abstract][Full Text] [Related]
74. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Dove-Edwin I; Boks D; Goff S; Kenter GG; Carpenter R; Vasen HF; Thomas HJ Cancer; 2002 Mar; 94(6):1708-12. PubMed ID: 11920532 [TBL] [Abstract][Full Text] [Related]
75. MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer. McCoy P; Mangiola S; Macintyre G; Hutchinson R; Tran B; Pope B; Georgeson P; Hong MKH; Kurganovs N; Lunke S; Clarkson MJ; Cmero M; Kerger M; Stuchbery R; Chow K; Haviv I; Ryan A; Costello AJ; Corcoran NM; Hovens CM Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1167-1180. PubMed ID: 34108644 [TBL] [Abstract][Full Text] [Related]
77. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Watson P; Vasen HF; Mecklin JP; Järvinen H; Lynch HT Am J Med; 1994 Jun; 96(6):516-20. PubMed ID: 8017449 [TBL] [Abstract][Full Text] [Related]
78. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Rijcken FE; Mourits MJ; Kleibeuker JH; Hollema H; van der Zee AG Gynecol Oncol; 2003 Oct; 91(1):74-80. PubMed ID: 14529665 [TBL] [Abstract][Full Text] [Related]
79. Somatic polymerase epsilon mutations as another route leading to loss of DNA MMR protein expression in endometrial carcinoma. Westenend PJ; Dinjens WN Hum Pathol; 2018 Jun; 76():169. PubMed ID: 29634980 [No Abstract] [Full Text] [Related]
80. Characteristics of hereditary nonpolyposis colorectal cancer patients with double primary cancers in endometrium and colorectum. Shin SH; Yu EJ; Lee YK; Song YS; Seong MW; Park SS Obstet Gynecol Sci; 2015 Mar; 58(2):112-6. PubMed ID: 25798424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]